XBIOTECH INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
XBIOTECH INC. (XBIT) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $114.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $114.00K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $284.00K.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $400.00K.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $150.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $114.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $284.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $400.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $150.00M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $98.00M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $211.00M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $400.00K 10-K · filed 2025-03-18 |
| 2024-09-30 | $895.00M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.40M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.10M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.40M 10-K · filed 2024-03-15 |
| 2023-09-30 | $2.10M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.10M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.70M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.80M 10-K · filed 2023-03-15 |
| 2022-09-30 | $4.00M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $5.40M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $6.80M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $8.40M 10-K · filed 2022-03-15 |
| 2021-09-30 | $4.30M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.10M 10-Q · filed 2022-08-10 |
| 2021-03-31 | $5.10M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $6.30M 10-K · filed 2021-03-16 |
| 2020-09-30 | $9.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $10.50M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $13.60M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $16.50M 10-K · filed 2020-03-16 |
| 2018-12-31 | $3.00M 10-K/A · filed 2019-03-15 |
| 2018-09-30 | $3.00M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $3.20M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.00M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $3.80M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.50M 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |